Abstract
The case of a patient who had a relapse of cerebral Whipple ’s disease (WD) one year after discontinuation of a two-years’ antibiotic treatment is reported. Neither the clinical course nor the results of magnetic resonance imaging (MRI) and routine examination of the cerebrospinal fluid (CSF) allowed the caring physician to predict the relapse. Retrospective analysis of serial specimens of CSF showed that slight CSF leucocytosis and intrathecal synthesis of IgA might have suggested persistence of infection. The decision to stop antibiotic therapy in cerebral WD is difficult, but evaluation of cell counts and of intrathecal synthesis of IgA may help in the decision. Some patients may need to take treatment indefinitely.
Similar content being viewed by others
References
Adams M, Rhyner PA, Day J, DeArmand S, Smuckler EA (1987) Whipple’s disease confined to the central nervous system. Ann Neurol 21:104–108
Keinath RD, Merrel DE, Vlietstra R, Dobbins III WO (1985) Antibiotic treatment and relapse in Whipple’s disease. Longterm follow-up of 88 patients. Gastroenterology 88:1867–1873
Fleming JL, Wiesner RH, Shorter RG (1988) Whipple’s disease: Clinical biochemical and histopathological features and assessment of treatment in 29 patients. Mayo Clin Proc 63:539–551
Bernardi G, Terrani C, Malesani L, Frigerio S, Nespolo A (1993) La determinazione immunochimica quantitativa al lattice in fase omogenea delle IgM liquorali: Dosaggio in au tomazione e confronto con il metodo ELISA. Biochim Clinica 17 [Suppl 1/9]:111
Nespolo A, Bianchi G, Salmaggi A, Lazzaroni M, Cerrato D, Malesani Tajoli L (1989) Immunoblotting techniques with picogram sensitivity in cerebrospinal fluid protein detection. Electrophoresis 10:34–40
Reiber HO, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the Immoral immune response within the central nervous system. Clin Chim Acta 163:319–328
Andersson M, Alvarez-Cermeño J, Bemardi G et al (1994) Cerebrospinal fluid in the diagnosis of multilple sclerosis: A consensus report. J Neurol Neurosurg Psychiatry 57:897–902
Luis ED, Lynch T, Kaufmann P, Fahn S, Odel J (1996) Diagnostic guidelines in central nervous system Whipple’s disease. Ann Neurol 40:561–568
Cohen L, Berthet K, Dauga C, Thivart L, Pierrot-Deseilligny C (1996) Polymerase chain reaction of cerebral spinal fluid to diagnose Whipplé s disease. Lancet 347:329
Weeks RA, Scott J, Brooks DJ, Hodgson H, Cohen J, Lynn WA (1996) Cerebral Whipple’s disease. BMJ 312:371–373
Ramzan NN, Loftus Jr E, Burgart LJ et al (1997) Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med 126:520–527
Wroe SJ, Pires M, Harding B, Youl BD, Shorvon S (1991) Whipple’s disease confined to the CNS presenting with multiple intracerebral mass lesions. J Neurol Neurosurg Psychiatry 54:989–992
Badenoch J, Richards WCD, Oppenheimer DR (1963) Encephalopathy in a case of Whipple’s disease. J Neurol Neurosurg Psychiatry 26:203–210
Sieracki JC, Fine G, Horn Jr RC, Bebin J (1960) Central nervous system involvement in Whipple’s disease. J Neuropathol Exp Neurol 19:70–75
Davion T, Rosat P, Sevestre H, Desamblens B, Debussche C, Delamarre J, Capron JP (1990) MR imaging of CNS relapse of Whipple disease. J Comput Assist Tomogr 14:815–817
Felgenhauer K, Schädlich HJ (1987) The compartmental IgM and IgA response within the central nervous system. J Neurol Sci 77:125–135
Relman DA, Schmidt TM, MacDermott RP, Falkow S (1992) Identification of the uncultured bacillus of Whipple’s disease. N Eng J Med 327:293–301
Keren DF (1993) Whipple’s disease: The causative agent defined. Its pathogenesis remains obscure. Medicine (Baltimore) 72:355–358
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carella, F., Valla, P., Bernardi, G. et al. Cerebral Whipple’s disease: clinical and cerebrospinal fluid findings. Ital J Neuro Sci 19, 101–105 (1998). https://doi.org/10.1007/BF02427566
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02427566